These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22716215)

  • 1. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration.
    Choi JH; Yoon JS; Won YW; Park BB; Lee YY
    APMIS; 2012 Jul; 120(7):597-604. PubMed ID: 22716215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.
    Sasaki K; Tsuno NH; Sunami E; Tsurita G; Kawai K; Okaji Y; Nishikawa T; Shuno Y; Hongo K; Hiyoshi M; Kaneko M; Kitayama J; Takahashi K; Nagawa H
    BMC Cancer; 2010 Jul; 10():370. PubMed ID: 20630104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study.
    Sasaki K; Tsuno NH; Sunami E; Kawai K; Hongo K; Hiyoshi M; Kaneko M; Murono K; Tada N; Nirei T; Takahashi K; Kitayama J
    Anticancer Drugs; 2012 Aug; 23(7):675-82. PubMed ID: 22561420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
    Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model.
    Li J; Hou N; Faried A; Tsutsumi S; Kuwano H
    Eur J Cancer; 2010 Jul; 46(10):1900-9. PubMed ID: 20231086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
    Sui X; Kong N; Wang X; Fang Y; Hu X; Xu Y; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan H; Han W
    Sci Rep; 2014 Apr; 4():4694. PubMed ID: 24733045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
    Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
    Lim YJ; Rhee JC; Bae YM; Chun WJ
    World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.
    Bijnsdorp IV; Peters GJ; Temmink OH; Fukushima M; Kruyt FA
    Int J Cancer; 2010 May; 126(10):2457-68. PubMed ID: 19816940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-fluorouracil on cell cycle regulatory proteins in human colon cancer cell line.
    Takeda H; Haisa M; Naomoto Y; Kawashima R; Satomoto K; Yamatuji T; Tanaka N
    Jpn J Cancer Res; 1999 Jun; 90(6):677-84. PubMed ID: 10429661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53.
    Russo P; Malacarne D; Falugi C; Trombino S; O'Connor PM
    Int J Cancer; 2002 Jul; 100(3):266-75. PubMed ID: 12115540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy.
    Chen J; Na R; Xiao C; Wang X; Wang Y; Yan D; Song G; Liu X; Chen J; Lu H; Chen C; Tang H; Zhuang G; Fan G; Peng Z
    Oncogene; 2021 Jun; 40(23):3974-3988. PubMed ID: 33990700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TiO
    Azimee S; Rahmati M; Fahimi H; Moosavi MA
    Life Sci; 2020 May; 248():117466. PubMed ID: 32101760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice.
    Liu L; Qiu S; Liu Y; Liu Z; Zheng Y; Su X; Chen B; Chen H
    Neoplasma; 2016; 63(2):193-200. PubMed ID: 26774139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].
    Katona C; Timár F; Oláh J; Bocsi J; Budai B; Otvös L; Kralovánszky J
    Magy Onkol; 2004; 48(3):243-51. PubMed ID: 15520875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil.
    Hirai H; Arai T; Okada M; Nishibata T; Kobayashi M; Sakai N; Imagaki K; Ohtani J; Sakai T; Yoshizumi T; Mizuarai S; Iwasawa Y; Kotani H
    Cancer Biol Ther; 2010 Apr; 9(7):514-22. PubMed ID: 20107315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
    Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.